Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert opinion on biological therapy"
DOI: 10.1080/14712598.2022.1998450
Abstract: BACKGROUND Talimogene laherparepvec (T-VEC) improves overall survival (OS) in unresectable stage IIIB/C-IV melanoma.1 T-VEC may have synergistic effects with CTLA-4 inhibitors.2 In the absence of a trial comparing T-VEC and ipilimumab (T-VEC+IPI) to T-VEC, we…
read more here.
Keywords:
melanoma;
versus vec;
ipi;
therapy ... See more keywords